We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+3.11%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$10.9B
AUM Growth
+$433M
Cap. Flow
+$143M
Cap. Flow %
1.31%
Top 10 Hldgs %
18.12%
Holding
2,433
New
160
Increased
1,129
Reduced
851
Closed
234
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBT
2101
Permian Basin Royalty Trust
PBT
$1.53B
$94K ﹤0.01%
15,476
-986
-6% -$6.34K
DDD icon
2102
3D Systems Corp
DDD
$620M
$93K ﹤0.01%
10,186
-13,364
-57% -$127K
TAST
2103
DELISTED
Carrols Restaurant Group, Inc.
TAST
$90K ﹤0.01%
+10,000
New +$91.8K
NG icon
2104
NovaGold Resources
NG
$3.37B
$89K ﹤0.01%
15,077
PTE
2105
DELISTED
PolarityTE, Inc. Common Stock
PTE
$89K ﹤0.01%
+624
New +$118K
MFM
2106
Aberdeen Municipal Income Fund
MFM
$223M
$88K ﹤0.01%
12,557
+1,328
+12% +$9.14K
RES icon
2107
RPC Inc
RES
$1.38B
$87K ﹤0.01%
12,085
+14
+0.1% +$133
VVR icon
2108
Invesco Senior Income Trust
VVR
$459M
$87K ﹤0.01%
20,054
+2,069
+12% +$8.83K
GPRO icon
2109
GoPro
GPRO
$104M
$85K ﹤0.01%
15,491
-21
-0.1% -$133
WATT icon
2110
Energous
WATT
$103M
$85K ﹤0.01%
32
-2
-6% -$5.84K
AWP
2111
abrdn Global Premier Properties Fund
AWP
$363M
$84K ﹤0.01%
+4,491
New +$81.2K
ERF
2112
DELISTED
Enerplus Corporation
ERF
$84K ﹤0.01%
11,099
-848
-7% -$6.95K
CBAY
2113
DELISTED
Cymabay Therapeutics
CBAY
$80K ﹤0.01%
+11,200
New +$127K
EDD
2114
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$384M
$79K ﹤0.01%
+11,473
New +$76.3K
SOHO
2115
DELISTED
Sotherly Hotels
SOHO
$79K ﹤0.01%
+11,400
New +$80.4K
AEG icon
2116
Aegon
AEG
$14B
$78K ﹤0.01%
17,673
-683,695
-97% -$2.91M
PNNT
2117
Pennant Park Investment Corp
PNNT
$244M
$77K ﹤0.01%
+12,171
New +$81.9K
SMFG icon
2118
Sumitomo Mitsui Financial
SMFG
$161B
$77K ﹤0.01%
+10,877
New +$77K
NSLR
2119
Neostellar Capital Corp
NSLR
$272M
$77K ﹤0.01%
14,355
-509
-3% -$2.82K
TSI
2120
TCW Strategic Income Fund
TSI
$213M
$76K ﹤0.01%
13,161
+1,809
+16% +$10.1K
NBEV
2121
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$75K ﹤0.01%
16,090
-4,665
-22% -$23.9K
GCV
2122
Gabelli Convertible and Income Securities Fund
GCV
$94.3M
$73K ﹤0.01%
14,174
+2,648
+23% +$13.5K
NWG icon
2123
NatWest
NWG
$76.1B
$72K ﹤0.01%
11,744
-1,501
-11% -$9.83K
CX icon
2124
Cemex
CX
$16.2B
$70K ﹤0.01%
16,458
-1,194
-7% -$5.33K
OCSL icon
2125
Oaktree Specialty Lending
OCSL
$1.12B
$66K ﹤0.01%
4,033
-667
-14% -$10.8K

Similar funds

Cambridge Investment Research Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Cambridge Investment Research Advisors held 2,433 positions worth $10.9B, up 4.1% from $10.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors's Q2 2019 filing shows 160 new, 1,129 increased, 851 reduced and 234 closed positions. Its largest new stake was WisdomTree International ESG Fund: 441,613 shares worth $10.6M. The largest sale was Vanguard S&P 500 ETF, an estimated $38M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.3% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q2 2019 buy was WisdomTree International ESG Fund: 441,613 shares worth $10.6M.
  • Cambridge Investment Research Advisors added most to Vanguard Short-Term Treasury ETF in Q2 2019, an estimated $27M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2019 reduction was Vanguard S&P 500 ETF, cutting an estimated $38M.
  • Cambridge Investment Research Advisors fully exited DuPont de Nemours in Q2 2019, selling an estimated $17.5M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $10.9B portfolio in Q2 2019.
  • Cambridge Investment Research Advisors opened 160 new positions and closed 234 in Q2 2019.
  • Cambridge Investment Research Advisors's portfolio value rose 4.1% quarter-over-quarter to $10.9B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2019, filed 15 Aug 2019.